Breakthroughs in advances in endocrine research and molecular endocrinology are revolutionizing the diagnosis and treatment of metabolic diseases. The discovery of novel hormone signaling pathways has deepened understanding of insulin resistance and beta-cell dysfunction. Molecular research has also identified genetic markers linked to endocrine disorders, paving the way for personalized medicine. Gene-editing technologies, including CRISPR, are being explored for their potential in correcting inherited hormonal deficiencies. Emerging therapies targeting hormonal receptors offer new treatment avenues for diabetes and obesity-related conditions. By combining molecular endocrinology with clinical applications, scientists are developing innovative strategies to improve endocrine health and metabolic stability.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti